Skip to Content
Agencies | Governor
Search Virginia.Gov
Protecting You and Your Environment Virginia Department of Health
Home | VDH Programs | Find It! A-Z Index | Newsroom | Administration | Jobs

Virginia Adult Hepatitis B Immunization Initiative (VAHBII)


Program Coordinator: Bethany McCunn, MPH

HBII

The Virginia Adult Hepatitis B Initiative is a collaborative effort between the Virginia Department of Health’s Immunization Division, local health departments and community partners to identify adults at high risk for hepatitis B infection and to provide free hepatitis B vaccine to these individuals for the prevention of hepatitis B infection.

Hepatitis B Facts:

  • Hepatitis B virus (HBV) can cause a serious infection that affects the liver. 
  • In 2009, about 38,000 people in the U.S became infected with hepatitis B. 
  • Each year, 2,000 to 4,000 persons in the U.S die from complications caused by hepatitis B.
  • In recent years, adults in high risk groups have accounted for most new HBV infections.
  • A safe, effective hepatitis B vaccine and a combination hepatitis A/hepatitis B vaccine are available.
  • Greater than 90% of healthy adults develop a protective antibody response after 3 valid doses of vaccine.

Qualifying for the Vaccine:

  • Through the Adult Hepatitis B Immunization Initiative, hepatitis B vaccine is available to those 19 years of age and older who are hepatitis B-susceptible and who meet one (or more) of the following conditions:
  • Sexually active persons with multiple partners (more than one partner during the previous 6 months)
  • Men who have sex with men (MSM)
  • Current or recent injection-drug users (IDU)
  • Household and sexual contact(s) of  hepatitis B infected persons
  • Persons with HIV infections
  • Persons seeking evaluation or treatment for an STD
  • Persons with diabetes mellitus
  • If you are a patient interested in the program, contact your local health department for clinic dates and times.  
  • If you are a patient being seen at an opiate treatment center (OTC), you may qualify.  Contact your OTC for information.
  • Patients meeting criteria are offered the first dose of the three-dose series as they present.  Subsequent doses are given according to the recommended schedule.

Forms for Participating Sites

Contact Information

  • If you are a patient interested in the program, contact your local health department.
  • For more information on site enrollment in the program, you can contact Bethany McCunn, Deputy Division Epidemiologist, Division of Immunization, Virginia Department of Health at (804) 864-8055. 

Patient Education Materials

Resources


Last Updated: 10-23-2013

Printable Version

E-mail This Page